Publications by authors named "N G Kucheriaeva"
Article Synopsis
- The study tested a new buccal dosage form of aspirin called ascolong, which has a low dose of 12.5 mg of acetylsalicylic acid (ASA), focusing on its safety and effectiveness.
- The research involved 43 healthy men for drug tolerance and 19 patients with heart or vascular issues, comparing the effects of ascolong with placebo and traditional aspirin.
- Results showed ascolong provided a reliable antiaggregant effect, albeit weaker than regular aspirin, and was well-tolerated, making it a potential option for those who cannot take oral aspirin.
